Cigna has sold its Medicare businesses and slashed the number of people it covers in its ACA plans by more than half.

Full year 2025 pretax adjusted earnings outlooks for Evernorth and Cigna Healthcare remain at "at least $7.2 billion" and "at least $4.125 billion" respectively. The company expects the full year ...

Several new weight loss drugs are undergoing trials in the UK. These drugs will work similarly to those already available but ...

Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...

Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

Some patients prescribed GLP-1 drugs for weight loss have had to switch to a different medication due to changes in insurance ...

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

The report, compiled for The New York Times by health analytics company Komodo Health, shows that denial rates rose from 18.3 ...

UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 ...

Prescription denial rates from private insurers grew from 18.3% in 2016 to 22.9% in 2023 — a 25% increase, according to a July 18 article from The New York Times.  Healthcare analytics company Komodo ...